Bayer to appeal $2 billion glyphosate-cancer verdict with EPA Roundup assessment excluded from trial

monsanto roundup

Bayer plans to make the EPA’s safety endorsement of a chemical in Roundup central to its case as the company fights claims its weedkiller causes cancer.

In recent months, Bayer has been handed three jury verdicts ordering the company to pay more than $2 billion in damages to plaintiffs who believe exposure to Roundup caused their non-Hodgkin lymphoma ….

…. In April, the EPA released a draft risk assessment stating glyphosate is not a carcinogen …. a conclusion the agency has consistently made as it periodically reviews the herbicide. Attorneys for Bayer tried to introduce that evidence during the third trial …. but were rebuffed by the judge.

Related article:  California judge orders expedited trial for couple alleging glyphosate caused their cancer

Defense attorneys plan to make that judge’s ruling a key part of their attempt to overturn the third jury verdict during appeal

Read full, original article: Bayer to lean on EPA review of glyphosate in court battles (Behind Paywall)

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend